Disclosure Of Interests In Other Entities [Text Block]

Innate Pharma - Filing #2811003

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	—	—	148 012 EUR	—	—	—	—	—	—	139 831 EUR	—	—	—	—	—	—	—	—	—
Non-current assets	—	—	36 181 EUR	—	—	—	—	—	—	68 033 EUR	—	—	—	—	—	—	—	—	—
Current liabilities	—	—	39 637 EUR	—	—	—	—	—	—	41 338 EUR	—	—	—	—	—	—	—	—	—
Non-current liabilities	—	—	92 656 EUR	—	—	—	—	—	—	112 374 EUR	—	—	—	—	—	—	—	—	—
Revenue	61 641 EUR	—	—	—	—	—	—	—	—	—	—	57 674 EUR	—	—	—	—	—	—	—
Profit (loss)	7 570 EUR	— EUR	—	7 570 EUR	— EUR	— EUR	— EUR	— EUR	— EUR	—	— EUR	58 103 EUR	— EUR	58 103 EUR	— EUR	— EUR	— EUR	— EUR	—
Comprehensive income	6 900 EUR	324,000 EUR	—	7 570 EUR	994,000 EUR	— EUR	— EUR	— EUR	— EUR	—	— EUR	57 741 EUR	— EUR	58 103 EUR	— EUR	— EUR	362,000 EUR	— EUR	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Profit (loss) from continuing operations	7 570 EUR	—	—	—	—	—	—	—	—	—	—	57 972 EUR	—	—	—	—	—	—	—
Profit (loss) from discontinued operations	— EUR	—	—	—	—	—	—	—	—	—	—	131,000 EUR	—	—	—	—	—	—	—
Other comprehensive income	670,000 EUR	—	—	—	—	—	—	—	—	—	—	362,000 EUR	—	—	—	—	—	—	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	—	—	70 605 EUR	—	—	—	—	—	—	84 225 EUR	—	—	—	—	—	—	—	—	103 756 EUR
Tax expense (income)	— EUR	—	—	—	—	—	—	—	—	—	—	— EUR	—	—	—	—	—	—	—